We are live on ! Find out more
OFIX icon

Orthofix Medical

136 hedge funds and large institutions have $519M invested in Orthofix Medical in 2024 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 44 increasing their positions, 55 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more funds holding in top 10

Funds holding in top 10: 34 (+1)

2% more capital invested

Capital invested by funds: $511M → $519M (+$7.96M)

7.54% less ownership

Funds ownership: 103.17%95.62% (-7.5%)

13% less funds holding

Funds holding: 156136 (-20)

20% less repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 55

47% less call options, than puts

Call options by funds: $40K | Put options by funds: $75K

69% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 26

Holders
136
Holders Change
-20
Holders Change %
-12.82%
% of All Funds
1.96%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.06%
New
8
Increased
44
Reduced
55
Closed
26
Calls
$40K
Puts
$75K
Net Calls
-$35K
Net Calls Change
-$35K
Name Holding Trade Value Shares
Change
Change in
Stake
Russell Investments Group
26
Russell Investments Group
United Kingdom
$3.21M -$175K -12,670 -5%
ACM
27
AREX Capital Management
New York
$3.19M +$2.33M +168,632 +328%
AG
28
Algert Global
California
$3.13M -$470K -33,987 -14%
Citadel Advisors
29
Citadel Advisors
Florida
$3.06M -$830K -60,026 -22%
N
30
Nuveen
North Carolina
$3.05M -$739K -53,476 -20%
Goldman Sachs
31
Goldman Sachs
New York
$2.89M +$848K +61,305 +45%
VOYA Investment Management
32
VOYA Investment Management
Georgia
$2.78M -$311K -22,494 -11%
MOACM
33
Mutual of America Capital Management
New York
$2.55M +$322K +23,324 +15%
HS
34
HighVista Strategies
Massachusetts
$2.44M +$2.32M +167,900 New
Barclays
35
Barclays
United Kingdom
$2.29M +$697K +50,423 +47%
GI
36
GAMCO Investors
Connecticut
$2.17M +$358K +25,900 +21%
GF
37
Gabelli Funds
New York
$2.12M +$89.9K +6,500 +5%
Bank of New York Mellon
38
Bank of New York Mellon
New York
$1.96M -$276K -19,982 -13%
CSS
39
Cubist Systematic Strategies
Connecticut
$1.88M -$1.33M -95,990 -43%
CCP
40
Clough Capital Partners
Massachusetts
$1.78M -$185K -13,410 -10%
Renaissance Technologies
41
Renaissance Technologies
New York
$1.71M -$3.07M -221,782 -65%
Tudor Investment Corp
42
Tudor Investment Corp
Connecticut
$1.39M +$678K +49,049 +105%
Jane Street
43
Jane Street
New York
$1.26M -$2.64M -191,015 -69%
UOC
44
UBS O'Connor
Illinois
$1.22M +$55.3K +4,000 +5%
Man Group
45
Man Group
United Kingdom
$1.19M +$981K +70,951 +663%
Invesco
46
Invesco
Georgia
$1.11M +$294K +21,233 +39%
KCM
47
Kennedy Capital Management
Missouri
$1.03M -$3.68K -266 -0.4%
Deutsche Bank
48
Deutsche Bank
Germany
$1.01M +$7.98K +577 +0.8%
EGM
49
Engineers Gate Manager
New York
$989K +$265K +19,176 +39%
Swiss National Bank
50
Swiss National Bank
Switzerland
$948K -$98.2K -7,100 -10%

OFIX Hedge Fund Activity: Q1 2024 in Review

136 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Orthofix Medical (OFIX) for Q1 2024, worth a combined $519M — up 1.6% from $511M a quarter earlier.

Sellers outnumbered buyers: 26 funds closed out of OFIX and 8 opened new positions — a net loss of 18 holders — while 55 trimmed existing stakes and 44 added.

The largest buyer was Paradigm Capital Management Inc, adding an estimated $14M. The largest seller was Morgan Stanley, cutting an estimated $19.7M.

  • 136 institutional investors held Orthofix Medical (OFIX) as of Q1 2024, down from 156 in Q4 2023.
  • Funds reported $519M of Orthofix Medical stock for Q1 2024, up 1.6% quarter-over-quarter.
  • 8 funds opened new Orthofix Medical positions in Q1 2024 and 26 closed out, a net change of -18 holders.
  • The largest Orthofix Medical buyer in Q1 2024 was Paradigm Capital Management Inc, an estimated $14M added.
  • The largest Orthofix Medical seller in Q1 2024 was Morgan Stanley, an estimated $19.7M sold.

Based on aggregated 13F filings for Q1 2024.